Clin2
NCT05713799Possibly a fitNot yet recruiting

Combination treatment for weight loss in adults with obesity

Insulin ResistanceObesity

Treatments studied

Part of Hormones & metabolism clinical trials.

This trial tests a combination of two medicines, alpha-lipoic acid (an antioxidant) and mirabegron (a drug for bladder issues), to see if they help people with obesity lose weight and improve metabolism. You would receive the treatment for a period of time while researchers monitor your progress.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
60 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You must be between 18 and 65 years old.
  • Your body mass index (BMI) must be between 30 and 45, which is in the obesity range.
  • You must not have diabetes or be taking blood sugar-lowering medications.
  • Your blood pressure must be well-controlled, under 140/90 mmHg.
  • You must not have had significant weight loss or used weight-loss medications in the last 6 months.
  • You must be willing to eat the study-provided meals and follow the study plan.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07793019Recruiting· Phase 1
Weight loss and safety study in overweight adults

This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.

Beijing, Beijing Municipality
NCT06143956Recruiting· Phase 2
Weight loss treatments for adults with obesity

This clinical trial tests new treatments for adults who are overweight or have obesity. The goal is to help people lose weight and improve their health.

Chandler, Arizona
NCT07738614Recruiting· Phase 1
Testing an investigational weight loss medicine for adults with overweight or obesity

This study tests an experimental medicine (eloralintide) to see if it can help people with overweight or obesity lose weight without having diabetes. The medicine works by affecting hormones that help control appetite and body weight.

San Antonio, Texas
NCT07437079Recruiting· Phase 1
Testing a new weight-loss medicine in healthy people

This study tests a new medicine (NNC6989-0001) for people who are overweight or have obesity. It checks if the medicine is safe and how the body handles it. If eligible, you would receive the study drug and be monitored closely.

Lenexa, Kansas
NCT07822061Recruiting· Phase 3
Weight loss study for people with excess weight

This study tests an investigational medicine for weight loss in people with excess weight. It aims to see how effective the medicine is and may help you lose weight and improve health.

Sapporo, Hokkaido
NCT07339423Recruiting· Phase 3
A study of a new medicine for weight loss

This study tests a new medicine to see how well it helps people with excess body weight lose weight. It may be an option if you have tried to lose weight through dieting before but haven't had lasting success.

Miramar, Florida

Hear when a new Insulin Resistance trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.